Results 51 to 60 of about 2,641 (143)

The future directions of artificial intelligence in the biological benefit-dominated diagnosis and treatment of pancreatic cancer [PDF]

open access: yes
Pancreatic cancer is a high malignant tumor with insidious onset, early metastasis, and extremely poor prognosis. How to improve the early diagnosis and the prognosis of the patients is the current research focus.
QI Zhong, XING Ying, CHENG Shi
core   +1 more source

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023 [PDF]

open access: yes
Pancreatic cancer is a highly malignant digestive tract tumor with hidden symptoms, limited treatment options and rapid progression. With an increasing incidence rate year by year, pancreatic cancer has increasingly become a prominent issue endangering ...
LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun
core   +1 more source

肿瘤标志物联合检测与胰腺影像学检查在早期胰腺癌筛查诊断中的比较分析

open access: yesZhongguo shiyan zhenduanxue, 2015
胰腺癌是消化系统恶性程度很高的肿瘤。近年来其发病率有明显增加趋势[1]。由于胰腺位于腹膜后,位置深,早期无明显症状,故胰腺癌易被忽略而延误诊断,得不到及时有效的治疗。数十年来胰腺癌死亡率和生存率一直没有明显的改观。其主要原因是对胰腺癌早期诊断十分困难,各项生化检查对诊断胰腺癌意义不大,因此寻找理想的早期检测方法,建立早期诊断体系,成为世界医学界研究的热点 ...
史桂兰, 黄琳
doaj  

Expressions of Cyr61 and WISP-3 in Non-small Cell Lung Cancer and Its Clinical Significance [PDF]

open access: yes, 2010
Background and objective Cysteine-rich protein 61 (Cyr61) plays a role as a tumor suppressor in non-small cell lung cancer (NSCLC). Cyr61 and WISP-3 have a very significant sequence homology, belonging to the same CCN gene family.
Chunwei ZHANG   +3 more
core  

Progress of magnetic iron oxide nanoparticles in targeted diagnosis and treatment of pancreatic cancer [PDF]

open access: yes
Pancreatic cancer has a very poor prognosis. Early diagnosis and treatment are especially critical for improving its prognosis. Nanotechnology has been widely used in the diagnosis and treatment of pancreatic cancer. Relying on the unique physicochemical
REN Jiaqiang, WU Shuai, MO Jiantao, ZHOU Cancan, HAN Liang, WU Zheng
core   +1 more source

TBC1D4在胰腺癌中表达上调及其诱导的体液免疫应答

open access: yesZhongguo shiyan zhenduanxue, 2010
目的先前利用胰腺癌患者血清筛选睾丸cDNA文库,获得胰腺癌相关抗原:TBC1D4。本研究分析TBC1D4在胰腺癌患者中的表达上调及其诱导的自身体液免疫应答。方法原核表达TBC1D4蛋白,金属镍鳌合亲和层析柱进行蛋白纯化,Western20blot检测22例胰腺癌患者的癌组织和对应癌旁组织TBC1D4表达情况;ELISA方法测定95胰腺癌患者与150例健康对照者血清中抗TBC1D4蛋白特异性抗体的水平。结果表达纯化重组蛋白TBC1D4,并诱导出多克隆抗体;胰腺癌癌组织TBC1D4蛋白表达水平显著上调 ...
姜小华   +7 more
doaj  

Advantages and advances in neoadjuvant therapy of pancreatic cancer [PDF]

open access: yes
Due to the characteristics of the insidious onset, difficult early diagnosis and high malignancy of pancrea-tic cancer, only a minority of patients still have the chance of surgical resection at the time of diagnosis.
HU Binwei, SHEN Baiyong
core   +1 more source

晚期胰腺癌患者血清CA125,CA199水平与肝转移的关系

open access: yesZhongguo shiyan zhenduanxue, 2017
目的分析晚期胰腺癌患者血清CEA,CA199水平与肝转移的关系,探讨胰腺癌肝转移的危险因素。方法选取101例胰腺癌患者,主要根据有无肝转移分组,肝转移70例,无肝转移31例。采用化学发光免疫法对其血清标本中癌胚抗原(CEA)、糖抗原19-9(CA19-9)、糖抗原125(CA125)、糖抗原72-4(CA72-4)、细胞角蛋白21-1(CYFRA21-1)等项目进行检测。结果血清CA19-9、CA125水平的增高与胰腺癌肝转移具有相关性 ...
杨柳, 闫欢, 石燕, 戴广海
doaj  

Composition Spectrum of Oral Microbiota Diversity in Patients with Pancreatic Cancer: A Systematic Review [PDF]

open access: yes
Objective To systematically evaluate the diversity of oral flora in patients with pancreatic cancer. Methods A cross-sectional study was conducted, focusing on the oral flora diversity profiles of patients with pancreatic cancer.
HUANG Hairong   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy